March 26 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:
INSILICO MEDICINE AND TENACIA BIOTECHNOLOGY EXPAND AI-DRIVEN CNS COLLABORATION WITH DEAL VALUE UP TO US$94.75 MILLION
INSILICO MEDICINE CAYMAN TOPCO - CO AND HYGTIA TO SHARE 50/50 GLOBAL RIGHTS; INSILICO ELIGIBLE FOR PAYMENTS OVER HK$500 MILLION
INSILICO MEDICINE CAYMAN TOPCO - RECEIVES FDA CLEARANCE TO INITIATE PARKINSON'S DISEASE CLINICAL TRIALS IN JAN 2026